Impact Of Chronic Disease Prevalence On The PET Nuclear Medicine Market: A Key Catalyst Accelerating Positron Emission Tomography (PET) Nuclear Medicine Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Positron Emission Tomography (PET) Nuclear Medicine Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for positron emission tomography (PET) nuclear medicine has experienced a swift expansion in the past few years. Its growth is projected to rise from $11.49 billion in 2024, reaching $13.2 billion in 2025 with a compound annual growth rate (CAGR) of 14.9%. The significant growth seen in the historic period can be related to factors such as the rising incidence of cardiovascular diseases, surged healthcare expenditures, growing prevalence of urological diseases, an increase in the elderly population, and a boost in the number of hospitals.

Positron Emission Tomography (PET) Nuclear Medicine Market Size Forecast: What's the Projected Valuation by 2029?
The market size of positron emission tomography (PET) nuclear medicine is anticipated to witness exponential growth in the forthcoming years, ballooning to $22.71 billion in 2029 with a compound annual growth rate (CAGR) of 14.5%. Factors driving this growth during the forecast period comprise of increasing expenditure on research and development, growing preference for minimally invasive diagnostic methods, enhancement of worldwide healthcare infrastructure, escalating demand for food and pharmaceutical packaging, and a surge in cancer cases. Key trends projected during the forecast period include technological progress, multimodal diagnosis, incorporation of artificial intelligence, digital PET systems, and individualized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-nuclear-medicine-global-market-report

What Are the Drivers Transforming the Positron Emission Tomography (PET) Nuclear Medicine Market?
The escalating prevalence of chronic illnesses is anticipated to stimulate the expansion of the positron emission tomography (PET) nuclear medicine market in the future. Chronic diseases are persistent health conditions that generally last for three months or more and may necessitate continual medical care or impact daily activities. The increase in these diseases can be attributed to factors like an aging population, lack of exercise, unhealthy diet, and environmental threats. PET nuclear medicine facilitates the management of chronic diseases by providing advanced imaging techniques that allow the early detection, accurate diagnosis, and continuous monitoring of these ailments. For example, as reported by the World Health Organization (WHO), a Switzerland-founded intergovernmental organization, in February 2024, there were about 20 million new cancer cases and 9.7 million deaths related to cancer in 2022. Furthermore, by 2050, new cancer cases are anticipated to surpass 35 million, showcasing a 77% rise from the 2022 figure. Therefore, the escalating prevalence of chronic illnesses fuels the expansion of the positron emission tomography (PET) nuclear medicine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19151&type=smp

What Long-Term Trends Will Define the Future of the Positron Emission Tomography (PET) Nuclear Medicine Market?
Prominent entities in the positron emission tomography (PET) nuclear medicine sector are creating innovative products, such as PET slice scanners, to provide crystal clear images of metabolic activity. PET slice scanner is a medical imaging tool that fuses positron emission tomography (PET) with advanced computational strategies to generate detailed, layered images of metabolic functions in the human body. This makes it easier to detect and track illnesses, particularly cancer. For example, in July 2024, Positron Corporation, an American nuclear medicine firm, introduced the NeuSight PET-CT 3D 64-slice scanner. This scanner has raised the bar for imaging and diagnostic precision, combining high-tech features with patient comfort and operational efficiency. It's designed to revolutionize cardiac PET imaging and delivers unmatched performance and value, making it perfectly suited for cardiology and oncology clinical trials. The NeuSight PET-CT outperforms in scanning speed and accuracy, deploying comprehensive anatomical and functional imaging for heart, tumor, and brain studies across several molecular imaging applications.

Which Segments in the Positron Emission Tomography (PET) Nuclear Medicine Market Offer the Most Profit Potential?
The positron emission tomography (PET) nuclear medicine market covered in this report is segmented -

1) By Type: F-18, Rb-82, Other Types
2) By Procedure: Diagnostic Procedures, Single Photon Emission Computed Tomography Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Brachytherapy Procedures
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Research Institutes

Subsegments:
1) By F-18 (Fluorine-18): F-18 FDG (Fluorodeoxyglucose), F-18 NaF (Sodium Fluoride), F-18 Fluorocholine
2) By Rb-82 (Rubidium-82): Rb-82 for Myocardial Perfusion Imaging, Rb-82 for Cardiac PET Stress Testing, Rb-82 for Other Cardiac Applications
3) By Other Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Ga-68 (Gallium-68)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19151&type=smp

Which Firms Dominate the Positron Emission Tomography (PET) Nuclear Medicine Market by Market Share and Revenue in 2025?
Major companies operating in the positron emission tomography (PET) nuclear medicine marker are Cardinal Health, Bayer AG, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Agfa HealthCare NV, Scripps Health, Shimadzu Corporation, Jubilant DraxImage Inc., Neusoft Medical Systems Co. Ltd., Toshiba America Medical Systems Inc., Lantheus Holdings Inc., Advanced Accelerator Applications, Bruker Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, Canon Medical Systems Corporation, Digirad Corporation, NorthStar Medical Radioisotopes LLC, Mediso Medical Imaging Systems Ltd.

Which Regions Offer the Highest Growth Potential in the Positron Emission Tomography (PET) Nuclear Medicine Market?
North America was the largest region in the positron emission tomography (PET) nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) nuclear medicine marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19151

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.